Abstract: The present invention relates to modulators of metalloproteinase activity.
Type:
Grant
Filed:
July 11, 2006
Date of Patent:
June 30, 2009
Assignee:
Wyeth
Inventors:
Phaik-Eng Sum, Jerauld Stanley Skotnicki, Steve Yik-Kai Tam, Tarek Suhayl Mansour, David Brian How, Joshua James Sabatini, Jason Shaoyun Xiang, Eric Feyfant
Abstract: The present invention relates to novel methods for the preparation of glutamic acid derivatives and intermediates thereof, and such compounds prepared by the novel methods.
Type:
Grant
Filed:
July 11, 2006
Date of Patent:
June 2, 2009
Assignee:
Wyeth
Inventors:
Ronald S. Michalak, Joseph Zeldis, Mel Jennings, David M. Blum, Timothy Doyle
Abstract: A glucuronide metabolite of tigecycline, and its corresponding epimer, have been identified in humans treated with tigecycline. Mass spectral data have been used to identify these structures.
Type:
Grant
Filed:
November 2, 2005
Date of Patent:
May 19, 2009
Assignee:
Wyeth
Inventors:
Ronald A. Jordan, William DeMaio, Matthew Hoffmann
Abstract: The present invention provides a 2-amino-5-heteroaryl-5-phenylimidazolone compound of formula I The present invention also provides methods for the use thereof to inhibit ?-secretase (BACE) and treat ?-amyloid deposits and neurofibrillary tangles.
Type:
Grant
Filed:
June 29, 2006
Date of Patent:
November 18, 2008
Assignee:
Wyeth
Inventors:
Ping Zhou, Michael Sotirios Malamas, Yanfang Li, Albert Jean Robichaud, Dominick Anthony Quagliato